Sarcomatrix Therapeutics Extended Investor Round
The Reno-based biotech company pushed its accredited investor offering deadline to October 31, 2026.
Live Poll
Is now a good time for you to invest in early-stage biotechnology startups?
Reno Biotech
The Reno-based biotech company pushed its accredited investor offering deadline to October 31, 2026.
Live Poll
Is now a good time for you to invest in early-stage biotechnology startups?